Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 5, 1998, Pages 1005-1011

  Laperriere, Normand J ^a   Leung, Phil M K ^b   McKenzie, Stephen ^c   Milosevic, Michael ^a   Wong, Shun ^a   Glen, Jennifer ^c   Pintilie, Melania ^b   Bernstein, Mark ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Brachytherapy; Glioblastoma multiforme; Prognostic factors; Randomized study

Indexed keywords

ADULT; AGED; ARTICLE; ASTROCYTOMA; BEAM THERAPY; BRACHYTHERAPY; CANCER RADIOTHERAPY; FOLLOW UP; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; REOPERATION; TUMOR BIOPSY; TUMOR RECURRENCE;

ADULT; AGED; ANALYSIS OF VARIANCE; ASTROCYTOMA; BRACHYTHERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; SUPRATENTORIAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 18744422314     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00159-X     Document Type: Article

References (36)

1. Walker M.D., Alexander E., Hunt W.E., MacCarty C.S., Mahaley M.S. Jr, Norrell H.S., Owens G., Ransohoff J., Wilson C.B., Gehan E.A., Strike T.A. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas A cooperative clinical trial . J. Neurosurg. 49:1978;333-343.
2. Kristiansen K., Hagen S., Kollevold T., Torvik A., Holme I., Nesbakken R., Hatlevoll R., Lindgren M., Brun A., Lindgren S., Notter G., Andersen A.P., Elgen K. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer. 47:1981;649-652.
3. Walker M.D., Strike T.A., Sheline G.E. An analysis of dose effect relationship in the radiotherapy of malignant glioma. Int. J. Radiat. Oncol. Biol. Phys. 5:1979;1725-1731.
4. Chang C.H., Horton J., Schoenfeld D., Salazer O., Perez-Tamayo R., Kramer S., Weinstein A., Nelson J.S., Tsukada Y. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer. 52:1983;997-1007.
5. Bashir R., Hochberg F., Oot R. Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields. Neurosurgery. 23:1988;27-30.
6. Wallner K.E., Galicich J.H., Krol G., Arbit E., Malkin M.G. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int. J. Radiat. Oncol. Biol. Phys. 16:1989;1405-1409.
7. Bernstein M., Gutin P.H. Interstitial irradiation of brain tumors A review . Neurosurgery. 9:1981;741-750.
8. Laperriere N.J. Radiobiology of brachytherapy. Gildenberg P.L., Tasker R.R. Textbook of stereotactic and functional neurosurgery. 1997;569-575 McGraw-Hill, New York.
9. Gutin P.H., Phillips T.L., Wara W.M., Leibel S.A., Hosobuchi Y., Levin V.A., Weaver K.A., Lamb S. Brachytherapy of recurrent malignant brain tumors with removable high-activity iodine-125 sources. J. Neurosurg. 60:1984;61-68.
10. Gutin P.H., Hosobuchi Y., Phillips T.L., Stupar T.A. Stereotactic interstitial irradiation for the treatment of brain tumors. Cancer Treat. Rep. 65:(Suppl 2):1981;103-106.
11. Hosobuchi Y., Phillips T.L., Stupar T.A., Gutin P.H. Interstitial brachytherapy of primary brain tumors. Preliminary report. J. Neurosurgery. 53:1980;613-617.
12. Gutin P.H., Leibel S.A., Wara W.M., Choucair A., Levin V.A., Philips T.L., Silver P., Da Silva V., Edwards M.S., Davis R.L. Recurrent malignant gliomas Survival following interstitial brachytherapy with high-activity iodine-125 sources . J. Neurosurg. 67:1987;864-873.
13. Kumar P.P., Good R.R., Jones E.O., Patil A.A., Leibrock L.G., McComb R.D. Survival of patients with glioblastoma multiforme treated by intraoperative high-activity cobalt 60 endocurietherapy. Cancer. 64:1989;1409-1413.
14. Bernstein M., Laperriere N., Leung P., McKenzie S. Interstitial brachytherapy for malignant brain tumors Preliminary results . Neurosurgery. 26:1990;371-379.
15. Bernstein M., Laperriere N., Glen J., Leung P., Thomason C., Landon A.E. Brachytherapy for recurrent malignant astrocytoma. Int. J. Radiat. Oncol. Biol. Phys. 30:1994;1213-1217.
16. Loeffler J.S., Alexander E., Hochberg F.H., Wen P.Y., Morris J.H., Schoene W.C., Siddon R.L., Morse R.H., Black P.M. Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int. J. Radiat. Oncol. Biol. Phys. 19:1990;1455-1462.
17. Gutin P.H., Prados M.D., Phillips T.L., Wara W.M., Larson D.A., Leibel S.A., Sneed P.K., Levin V.A., Weaver K.A., Silver P., et al. External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas NCOG study 6G-82-2 . Int. J. Radiat. Oncol. Biol. Phys. 21:1991;601-606.
18. Prados M.D., Gutin P.H., Phillips T.L., Wara W.M., Sneed P.K., Larson D.A., Lamb S.A., Ham B., Malec M.K., Wilson C.B. Interstitial brachytherapy for newly diagnosed patients with malignant gliomas The UCSF experience . Int. J. Radiat. Oncol. Biol. Phys. 24:1992;593-597.
19. Hitchon P.W., VanGilder J.C., Wen B.C., Jani S. Brachytherapy for malignant recurrent and untreated gliomas. Stereo. Funct. Neurosurg. 59:1992;174-178.
20. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
21. Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., Mantel N., McPherson K., Peto J., Smith P.G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br. J. Cancer. 35:1977;1-39.
22. Cox D.R. Regression models and lifetables. J. R. Stat. Soc. 34:1972;187-202.
23. Bernstein M., Lumley M., Davidson G., Laperriere N., Leung P. Intracranial arterial occlusion associated with high-activity iodine-125 brachytherapy for glioblastoma. J. Neurooncol. 17:1993;253-260.
24. Bleehen N.M., Stenning S.P. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br. J. Cancer. 64:1991;769-774.
25. Payne D.G., Simpson W.J., Keen C., Platts M.E. Malignant astrocytoma Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial . Cancer. 50:1982;2301-2306.
26. Florell R.C., Macdonald D.R., Irish W.D., Bernstein M., Leibel S.A., Gutin P.H., Cairncross J.G. Selection bias, survival, and brachytherapy for glioma [published erratum appears in J Neurosurg 1992 Sep;77(3):489]. J. Neurosurg. 76:1992;179-183.
27. Willis B.K., Heilbrun M.P., Sapozink M.D., McDonald P.R. Stereotactic interstitial brachytherapy of malignant astrocytomas with remarks on postimplantation computed tomographic appearance. Neurosurgery. 23:1988;348-354.
28. Salcman M., Sewchand W., Amin P.P., Bellis E.H. Technique and preliminary results of interstitial irradiation for primary brain tumors. J. Neurooncol. 4:1986;141-149.
29. Malkin M.G. Interstitial brachytherapy of malignant gliomas The Memorial Sloan-Kettering Cancer Center experience. [Review] . Recent Results Cancer Res. 135:1994;117-125.
30. Agbi C.B., Bernstein M., Laperriere N., Leung P., Lumley M. Patterns of recurrence of malignant astrocytoma following stereotactic interstitial brachytherapy with iodine-125 implants. Int. J. Radiat. Oncol. Biol. Phys. 23:1992;321-326.
31. Sneed P.K., Gutin P.H., Larson D.A., Malec M.K., Phillips T.L., Prados M.D., Scharfen C.O., Weaver K.A., Wara W.M. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int. J. Radiat. Oncol. Biol. Phys. 29:1994;719-727.
32. Loeffler J.S., Alexander E. III, Wen P.Y., Shea W.M. Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma. J. Natl. Cancer Inst. 82:1990;1918-1921.
33. Siddiqi S.N., Provias J., Laperriere N.J., Bernstein M. Effects of iodine-125 brachytherapy on the proliferative capacity and histopathological features of glioblastoma recurring after initial therapy. Neurosurgery. 40:1997;910-917.
34. Green S.B., Shapiro W.R., Burger P.C., Selker R.G., VanGilder J.C., Saris S., Malkin M.G., Mealey J. Jr, Neal J., Robertson J.T., Olson J. A randomized trial of interstitial radiotherapy boost for newly diagnosed malignant glioma. Brain Tumor Trial Cooperative Group Trial 8701. Proc. Am. Soc. Clin. Oncol. 13:1994;174.
35. Gaspar L.E., Fisher B.J., Macdonald D.R., LeBer D.V., Halperin E.C., Schold S.C., Cairncross J.G. Malignant glioma - Timing of response to radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 25:1993;877-879.
36. Wood J.R., Green S.B., Shapiro W.R. The prognostic importance of tumor size in malignant gliomas A computed tomographic scan study by the Brain Tumor Cooperative Group . J. Clin. Oncol. 6:1988;338-343.